Slone Partners Fills VP of Scientific Affairs Role for Cambridge Biomedical

We are pleased to have worked with Slone Partners on this important search. Linda is truly a remarkable scientist and a perfect cultural fit for our organization,” said Chairwoman and CEO of Cambridge Biomedical, Barbara Osband.

National executive search firm, Slone Partners, announces the placement of Linda Robbie, PhD, a well-versed leader with extensive assay development and biomarker expertise, as VP of Scientific Affairs at Cambridge Biomedical.

Established in 1997, Cambridge Biomedical is a Boston CRO specializing in bio-analytical assay development and sample testing services. The organization acts as a leading provider of customized assays for small and large molecules, biomarkers, and diagnostics.

In her new role, Dr. Robbie will serve as the head of science and innovation and will lead and direct all initiatives related to science and technology, clinical operations, and project management.

“Linda is an exceptional addition to our leadership team. Leveraging her unique people management skills and years of successful technology implementation, she will act as our key scientific point person interfacing with both our clients and internal teams. We are pleased to have worked with Slone Partners on this important search. Linda is truly a remarkable scientist and a perfect cultural fit for our organization,” said Chairwoman and CEO of Cambridge Biomedical, Barbara Osband.

Prior to joining Cambridge Biomedical, Dr. Robbie served as the Global Senior Director of Biomarkers and Translational Science at Q² Solutions Laboratories, a Quintiles-Quest Joint Venture, where she led assay development teams in the U.S. and overseas.

Dr. Robbie earned a Bachelor of Science, with honors, in Biochemistry from Heriot-Watt University in Edinburgh,…

Read the full article from the Source…

Back to Top